Peptides on podcasts.
Invest Like the Best × Alex Karnal — the trillion-dollar public-health revolution
Patrick O'Shaughnessy's Apr 2026 episode with bio-investor Alex Karnal makes the case that GLP-1s, PCSK9 inhibitors, and peptides collectively represent the largest public-health inflection since antibiotics. Here's the thesis, the chapters that matter for peptide buyers, and every compound mentioned.
FoundMyFitness × Dr Charles Brenner — what NAD actually does
Rhonda Patrick's interview with Dr Charles Brenner — the scientist who discovered NR (nicotinamide riboside) — is the most technically accurate breakdown of NAD biology in the public record. Here's why it matters to anyone buying NAD precursors or clinic NAD+ drips.
Diary of a CEO × Dr Alex Tatum — the peptide episode
Bartlett's mainstream-breakthrough peptide conversation with a decade-of-study clinician who gets plain-language right. Here are the compounds mentioned, with live prices.
Joe Rogan × Dr Kyle Gillett — peptides, BPC-157, GH secretagogues
Rogan's recurring-guest hormone doctor walks him through the peptide stacks doctors actually prescribe — and the ones research-chemical vendors are selling.
Peter Attia — The GLP-1 episode: tirzepatide, retatrutide, and the obesity pharmacology revolution
Attia's deep-dive on GIP/GLP-1/glucagon agonists — why tirzepatide displaced semaglutide, what retatrutide adds, and when orforglipron changes the economics.